Business, Life Sciences Leaders Launch 'We Work for Health' Economic Development and Jobs Campaign in Washington State
Posted on: Thursday, 23 April 2009, 08:04 CDT
We Work for Health today also announced the results of an Archstone Consulting study on the economic impact of the industry, indicating that Washington's biopharmaceutical industry alone directly employs close to 20,000 people, resulting in more than
The Archstone research shows that the average wage of a life sciences worker in
We Work for Health supports the growth of the entire life sciences sector, including biotechnology, biopharmaceutical and biomedical companies that develop innovative treatments to improve and save lives. In addition to improving the health and well-being of patients, the private companies and public institutions of Washington's life sciences sector play a critical role in the economic strength of
Through world-renowned research and academic institutions, biopharmaceutical and biotechnology companies, and global health organizations, Washington's life sciences industry has formed a unique innovation pipeline that creates high-paying jobs, drives economic activity and saves lives.
"We Work for Health will provide a voice for this crucial segment of our economy and the family-wage jobs it represents," said
Part of the We Work for Health mission will be to create an environment in which life sciences organizations can continue to thrive and innovate.
"To support this important industry, it is vital that we create the right policy framework so it remains a driving force in our state's economy," said
"We are proud to support this critical industry and its thousands of employees in
Life sciences is a major contributor to the "innovation pipeline" that defines Washington's cutting-edge business culture. Through philanthropic grants to academic and community organizations and investment in R&D that leads to technology transfer from labs to the marketplace, the industry is an important source of innovation in the state.
"In the midst of one of the most challenging economic times in memory, it's more important than ever that we support key industries," said Rogers Weed, director of the state Department of Community, Trade and Economic Development and We Work for Health co-chair. "Life sciences and global health play a major role in our innovation-based economy, including investing in research and development that leads to technology transfer from labs to the marketplace. By providing the support and resources to help this industry flourish, we can better position our region for when the economy rebounds."
"Through its innovative research, the life sciences industry of
For more information, please visit http://www.weworkforhealth.org/state/washington.
About We Work For Health
We Work for Health unites organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers, key opinion leaders and the media about the economic impact of the life sciences innovation pipeline in
We Work for Health Advisory Board
This growing, landmark campaign is supported by a number of key leaders, including:
Co-chairs
Life Sciences Discovery Fund, Dr.
Puget Sound Regional Council,
Washington Biotechnology and Biomedical Association,
Advisory Board
Allen Institute for Brain Science,
Amgen Inc.,
Association of Washington Business,
Bayer Inc.,
Downtown Seattle Association,
Economic Development Board of
Enterprise
Office of Gov.
PATH,
PhRMA
Seattle Biomedical Research Institute,
Seattle-Northwest Securities (SNW),
Snohomish County Economic Development Council,
Vulcan Inc.,
Washington Global Health Alliance,
Washington Research Council,
Washington Roundtable,
Media Contacts:
SOURCE We Work for Health
Source: PR Newswire
Related Articles
- Prix Galien USA Honors Innovation in Science and Biotech Industries
- MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance
- Microsoft Health & Life Sciences Developer and Solutions Conference to Feature the Latest Microsoft-Based Software Solutions
- Medifast, Inc. Director of Research & Development Co-Authors Health Book
- Research and Markets: The Evolving Strategies of Generics Company Teva and the Growing Acceptance of Generic Drugs in Japan, Read More Inside 'State of the Pharmaceutical Industry, 2007'
- Massachusetts State Science & Engineering Fair Names Executive Director
- NASA Awards North Dakota State Science Grant
- Soliant Health Contributes to Georgia State University College of Health and Human Sciences
- Health Professionals Are an Economic Engine for the U.S., Academic Health Center Leader Addresses State Legislators at NCSL Forum
- Wichita State University Sciences, Math and Engineering Researchers Benefit From Integrated SGI Altix 3000 Solution
User Comments (0)

RSS Feeds